Peptide half-life extension: divalent, small-molecule albumin interactions direct the systemic properties of Glucagon-Like Peptide 1 (GLP-1) analogues
doi: 10.3390/cells13221838 186
Read the full release: #Biotech #Obesity #ClinicalDevelopment #MetabolicDisease #LifeSciences To view or add a comment, sign in More Relevant Posts Relevant and informative meta-analysis from the Cholesterol Treatment Trialists Collaboration Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials The Lancet Group To view or add a comment, sign in ' ' , %
Mistake 3: Not accounting for the medication appetite reduction
This triple-G receptor approach may offer broader metabolic benefits, including improved energy expenditure and fat metabolism, although long-term safety and tolerability are still under investigation
More recently, the buzz is around a new trend: micro-dosing these medications